Macrophages and neurodegeneration.

Area of Science:

• Neuroimmunology
• Pathology of Multiple Sclerosis

Background:

• Multiple sclerosis (MS) is a chronic CNS inflammatory disease characterized by demyelination.
• Axonal loss, alongside demyelination, is increasingly recognized as a key driver of MS pathogenesis and progression.
• Axonal damage in MS lesions is associated with the presence of infiltrating immune cells.

Purpose of the Study:

• To review the role of the innate immune system, specifically macrophages, in causing axonal loss in MS.
• To examine the mechanisms by which activated macrophages contribute to axonal damage.
• To identify potential therapeutic targets for preventing axonal loss in MS.

Main Methods:

• Review of existing literature on MS, experimental autoimmune encephalomyelitis (EAE), and innate immunity.
• Analysis of the effects of macrophage-derived mediators on axonal integrity.
• Discussion of therapeutic strategies targeting macrophage infiltration and activation.

Main Results:

• Infiltrated macrophages in MS lesions contribute to axonal loss.
• Activated macrophages release mediators like pro-inflammatory cytokines, free radicals, glutamate, and metalloproteases that harm axons.
• Experimental autoimmune encephalomyelitis (EAE) models support the role of macrophages in axonal damage.

Conclusions:

• Activated macrophages are significant contributors to axonal loss in multiple sclerosis.
• Targeting activated macrophages and their mediators offers a promising therapeutic avenue to reduce axonal damage during MS exacerbations.
• Inhibiting monocyte infiltration across the blood-brain barrier could mitigate macrophage-induced axonal injury.